-
April 12, 2021 Ketamine Therapy Shows Benefits in Treating Depression Related to Childhood AbuseAdults with depression who were abused or neglected as children responded better to intravenous ketamine...
-
April 12, 2021 Psychedelics Company Atai Adds Brain-Computer Interface for Mental Health TreatmentAtai Life Sciences is working to combine psychedelics with brain-computer interfaces for mental health treatment.
-
April 9, 2021 The Company of Others: How Shared Psychedelic Experiences Influence OutcomesDoes taking psychedelics with others improve the experiences for all individuals? Researchers are looking at...
-
April 8, 2021 Psychedelic Conference to Explore Promising Therapies for Veterans, First RespondersThe Heroic Dose conference will explore the use of psychedelic therapies to treat post-traumatic stress...
-
April 8, 2021 Mydecine Prepares to Present Four Novel Psychedelic CandidatesColorado-based Mydecine is launching four new psychedelic candidates for use in treating conditions like anxiety...
-
March 30, 2021 Minnesota Gets Its First Psychedelic Medicine ClinicThe first psychedelic therapy clinic has opened in Minnesota. The Institute for Integrative Therapies will...
-
March 29, 2021 New Research Investigates Psilocybin as OCD TreatmentResearchers are looking at how psilocybin and other psychedelics may help with OCD (obsessive-compulsive disorder).
-
March 29, 2021 New Guidance Released for Ketamine, Esketamine Therapy UseSuggested guidances for use of ketamine and esketamine therapy have been published in the American...
-
March 26, 2021 Psychedelic Use Linked to 20% Decreased Hypertension Risk, Study FindsPsychedelic use may help to decrease the risk of hypertension, according to new research.
-
March 25, 2021 New Study Finds Possible Mechanism for Psilocybin’s Anti-Depressive EffectsScientists are closer to unraveling the mystery behind the psilocybin effects and its ability to...
